Portland, OR, April 29, 2019 (GLOBE NEWSWIRE) -- According to a report published by Allied Market Research, the global stroke management market accounted for $24.28 billion in 2017 and is expected to garner $36.75 billion by 2023, registering a CAGR of 7.1% during the forecast period, 2017-2023.
Request Report Sample at: https://www.alliedmarketresearch.com/request-sample/661
Rise in incidences of cardiac disorders, surge in geriatric population, and increased patient awareness drive the growth of the global stroke management market. However, limited insurance coverage along with high cost of devices impede market growth. Nonetheless, improvement in healthcare infrastructure in developing nations would provide lucrative opportunities to new market players in the future.
By type, the diagnostics segment is expected to continue its dominance in the future and occupy almost four-fifths of the overall share by 2023, owing to an increased number of diagnostics procedures for pre-detection of strokes when any signs or symptoms are noticed. The segment is also projected to register the highest CAGR of 8.5% during the forecast period. In addition, the therapeutics segment is poised to grow at a CAGR of 2.9% from 2017 to 2023.
By application, the ischemic stroke segment is expected to dominate the global market and generate more than four-fifths of the overall revenue by 2023. This is attributed to the increase in incidences of ischemic stroke. However, the hemorrhagic stroke segment is projected to grow at the highest CAGR of 7.7% during the forecast period.
Regionally, Asia-Pacific is projected to register the highest CAGR of 8.4% from 2017 to 2023, owing to rise in government healthcare expenditure and growth in demand for healthcare devices from a large pool of patient population, and improvement in healthcare infrastructure. However, North America occupied almost two-fifths of the overall market in 2017 and is expected to continue its dominance through 2023. This is attributed to rise in expenditure to upgrade healthcare systems and growing demand for technologically advanced devices for rapid & accurate distribution of medicines.
Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/661
The key players analyzed in the report include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corp., Bristol-Myers Squibb, Medtronic Plc., Cardinal Health, GE Healthcare, Siemens Healthcare, GlaxoSmithKline Plc., and Merck & Company. They have adopted different strategies including collaborations, joint ventures, partnerships, expansions, mergers & acquisitions, and others to gain a strong position in the industry.
About Us:
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.